$25.12
0.91% yesterday
Nasdaq, Oct 15, 10:00 pm CET
ISIN
US74265M2052
Symbol
PDEX

Pro-Dex, Inc. Stock price

$25.12
-7.50 22.99% 1M
-38.82 60.71% 6M
-21.63 46.27% YTD
-2.98 10.61% 1Y
+5.19 26.02% 3Y
-1.84 6.82% 5Y
+22.58 888.98% 10Y
+14.95 147.00% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
-0.23 0.91%

Key metrics

Basic
Market capitalization
$82.4m
Enterprise Value
$90.2m
Net debt
$7.8m
Cash
$7.2m
Shares outstanding
3.3m
Valuation (TTM | estimate)
P/E
9.3 | 10.4
P/S
1.2 | 1.2
EV/Sales
1.4 | 1.3
EV/FCF
negative
P/B
2.2
Financial Health
Equity Ratio
60.7%
Return on Equity
24.3%
ROCE
23.2%
ROIC
16.3%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$66.6m | $71.4m
EBITDA
$11.9m | $13.0m
EBIT
$10.7m | $11.4m
Net Income
$9.0m | $7.9m
Free Cash Flow
$-2.9m
Growth (TTM | estimate)
Revenue
23.7% | 7.2%
EBITDA
43.1% | 5.8%
EBIT
49.0% | 3.9%
Net Income
322.1% | -11.9%
Free Cash Flow
-155.9%
Margin (TTM | estimate)
Gross
29.3%
EBITDA
17.9% | 18.1%
EBIT
16.0%
Net
13.5% | 11.1%
Free Cash Flow
-4.4%
More
EPS
$2.7
FCF per Share
$-0.9
Short interest
32.7%
Employees
147
Rev per Employee
$450.0k
Show more

Is Pro-Dex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Pro-Dex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Pro-Dex, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Pro-Dex, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Pro-Dex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
67 67
24% 24%
100%
- Direct Costs 48 48
21% 21%
72%
20 20
34% 34%
29%
- Selling and Administrative Expenses 5.18 5.18
24% 24%
8%
- Research and Development Expense 3.64 3.64
14% 14%
5%
12 12
43% 43%
18%
- Depreciation and Amortization 1.24 1.24
7% 7%
2%
EBIT (Operating Income) EBIT 11 11
49% 49%
16%
Net Profit 8.99 8.99
322% 322%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Pro-Dex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pro-Dex, Inc. Stock News

Neutral
Accesswire
about one month ago
IRVINE, CA / ACCESS Newswire / September 4, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 fourth quarter and full-year ended June 30, 2025.
Positive
Seeking Alpha
5 months ago
Pro-Dex, Inc. experienced a 32% stock crash despite record Q3 2025 performance, presenting a buying opportunity for risk-tolerant investors. Q3 2025 revenue grew 22% YoY, with gross profit up 45% due to favorable product mix; operating income increased 64%. PDEX's PEG ratio of 0.27x indicates undervaluation compared to sector median, despite higher valuation multiples in other metrics.
Neutral
Accesswire
6 months ago
IRVINE, CA / ACCESS Newswire / May 1, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 third quarter ended March 31, 2025.

Company Profile

Pro-Dex, Inc. engages in the design, development, and manufacture of rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. It specializes in medical device and services, industrial and scientific, dental and component, repairs, and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding, and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Head office United States
CEO Richard Kirk
Employees 147
Founded 1994
Website www.pro-dex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today